Role of Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Seminoma: Recommendations from the European Association of Urology Guidelines Panel on Testicular Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40957845.
- Also identified by DOI 10.1016/j.eururo.2025.08.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We summarize the evidence on nerve-sparing retroperitoneal lymph node dissection for clinical stage IIA/B seminoma. When performed by expert surgeons, this procedure offers a chemotherapy-free survival rate of 80-85% with low morbidity.
Medical subject headings
- Testicular Neoplasms
- Lymph Node Excision
- Seminoma